Literature DB >> 18408952

Enema-induced severe hyperphosphatemia in children.

Ariane Biebl1, Andrea Grillenberger, Klaus Schmitt.   

Abstract

We report the case of a 13-year-old boy with Costello syndrome and chronic constipation who received phosphate-containing Fleet-pediatric enemas at regular intervals. The day before admission he was given four enemas for severe constipation. Within 24 h the boy had developed severe hyperphosphatemia (phosphate 17.75 mmol/L), hypertonic dehydration (sodium 171 mmol/L) and severe hypocalcemia (calcium 0.56 mmol/L). With early intervention and treatment, the child survived without sequelae. Osmotically acting hypertonic phosphate enemas may result in severe toxicity. Children with developmental delay often display bowel dysfunction and chronic constipation and are therefore high-risk patients. The accepted opinion-that these enemas are not absorbed and therefore systemically inactive-is not true. Physicians should be aware of the potentially lethal complications of this treatment, which is part of everyday clinical practice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18408952     DOI: 10.1007/s00431-008-0705-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  6 in total

1.  Acute phosphate nephropathy and renal failure.

Authors:  Simon Desmeules; Marc J Bergeron; Paul Isenring
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

2.  Hypocalcemic coma following two pediatric phosphate enemas.

Authors:  J F Sotos; E A Cutler; M A Finkel; D Doody
Journal:  Pediatrics       Date:  1977-09       Impact factor: 7.124

3.  Fatal acute sodium phosphate enemas intoxication.

Authors:  Raymond Farah
Journal:  Acta Gastroenterol Belg       Date:  2005 Jul-Sep       Impact factor: 1.316

4.  [Risk of phosphate enemas in the infant].

Authors:  M P Soumoy; A Bachy
Journal:  Arch Pediatr       Date:  1998-11       Impact factor: 1.180

5.  Costello syndrome: clinical diagnosis in the first year of life.

Authors:  M Cristina Digilio; Anna Sarkozy; Rossella Capolino; M Beatrice Chiarini Testa; Giorgia Esposito; Andrea de Zorzi; Renato Cutrera; Bruno Marino; Bruno Dallapiccola
Journal:  Eur J Pediatr       Date:  2007-08-29       Impact factor: 3.183

6.  Severe hyperphosphatemia and hypocalcemia following the rectal administration of a phosphate-containing Fleet pediatric enema.

Authors:  Jeanna M Marraffa; Alan Hui; Christine M Stork
Journal:  Pediatr Emerg Care       Date:  2004-07       Impact factor: 1.454

  6 in total
  6 in total

1.  Re: Enema-induced severe hyperphosphatemia in children.

Authors:  Michael Caswell
Journal:  Eur J Pediatr       Date:  2009-05-26       Impact factor: 3.183

2.  Flow-through peritoneal dialysis in neonatal enema-induced hyperphosphatemia.

Authors:  Dusan Kostic; Andre Broggin Dutra Rodrigues; Antônio Leal; Camila Metran; Meire Nagaiassu; Andréia Watanabe; Maria Esther Ceccon; Uenis Tannuri; Vera Hermina Koch
Journal:  Pediatr Nephrol       Date:  2010-06-06       Impact factor: 3.714

Review 3.  Severe hyperphosphatemia after administration of sodium-phosphate containing laxatives in children: case series and systematic review of literature.

Authors:  Hannah N Ladenhauf; Ottokar Stundner; Florian Spreitzhofer; Stefan Deluggi
Journal:  Pediatr Surg Int       Date:  2012-08       Impact factor: 1.827

4.  A Comparison of the Efficacy of Enema Solutions in Pediatric Emergency Department Patients.

Authors:  Julie Anderson; Ronald A Furnival; Lei Zhang; Scott A Lunos; Zujaja Sadiq; Jonathan R Strutt; Rahul Kaila; Marissa A Hendrickson
Journal:  J Emerg Med       Date:  2019-10-05       Impact factor: 1.484

5.  Ileus and Intra-Abdominal Hypertension due to Phosphate- Containing Enema.

Authors:  Başak Akyildiz; Meda Kondolot; Ali Yikilmaz; Duran Arslan; Selim Kurtoğlu
Journal:  Indian J Pediatr       Date:  2016-06-04       Impact factor: 1.967

Review 6.  Bowel management for the treatment of pediatric fecal incontinence.

Authors:  Andrea Bischoff; Marc A Levitt; Alberto Peña
Journal:  Pediatr Surg Int       Date:  2009-10-15       Impact factor: 1.827

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.